Curia is an end-to-end Contract Development and Manufacturing Organization with over 30 years of experience, a network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts, and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we are working with you every step of the way, to accelerate your next therapeutic to market.

To learn more visit us at curiaglobal.com